Search research articles
Contact Us
Filters
Showing results (61-70 of 184) with videos related to
Page
of 19
Sort By:
Leukemia
|
June 9, 2019
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML
Riikka Karjalainen, Minxia Liu, Ashwini Kumar, et al.
Cancer Research
|
August 18, 2010
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells
Santosh Gupta, Kristiina Iljin, Henri Sara, et al.
Leukemia
|
January 13, 2019
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
Helena Hohtari, Oscar Brück, Sami Blom, et al.
Scientific Reports
|
November 16, 2017
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
Sami Blom, Lassi Paavolainen, Dmitrii Bychkov, et al.
Plos One
|
May 11, 2010
A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses
Ville Härmä, Johannes Virtanen, Rami Mäkelä, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
December 15, 2006
Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes
Rolf I Skotheim, Reija Autio, Guro E Lind, et al.
Nucleic Acids Research
|
May 13, 2023
Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
Swapnil Potdar, Filipp Ianevski, Aleksandr Ianevski, et al.
Molecular Therapy. Oncology
|
December 5, 2024
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responses
Emilia Piki, Alice Dini, Frida Rantanen, et al.
The Journal of Pathology. Clinical Research
|
April 29, 2017
<i>PLA2G7</i> associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells
Laura Lehtinen, Paula Vainio, Harriet Wikman, et al.
Translational Oncology
|
November 27, 2021
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
Laura Kohtamäki, Mariliina Arjama, Siru Mäkelä, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 184) with videos related to
Sort By:
Page
of 19
Leukemia
|
June 9, 2019
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML
Riikka Karjalainen, Minxia Liu, Ashwini Kumar, et al.
Cancer Research
|
August 18, 2010
FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells
Santosh Gupta, Kristiina Iljin, Henri Sara, et al.
Leukemia
|
January 13, 2019
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
Helena Hohtari, Oscar Brück, Sami Blom, et al.
Scientific Reports
|
November 16, 2017
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
Sami Blom, Lassi Paavolainen, Dmitrii Bychkov, et al.
Plos One
|
May 11, 2010
A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses
Ville Härmä, Johannes Virtanen, Rami Mäkelä, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
December 15, 2006
Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes
Rolf I Skotheim, Reija Autio, Guro E Lind, et al.
Nucleic Acids Research
|
May 13, 2023
Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data
Swapnil Potdar, Filipp Ianevski, Aleksandr Ianevski, et al.
Molecular Therapy. Oncology
|
December 5, 2024
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responses
Emilia Piki, Alice Dini, Frida Rantanen, et al.
The Journal of Pathology. Clinical Research
|
April 29, 2017
<i>PLA2G7</i> associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells
Laura Lehtinen, Paula Vainio, Harriet Wikman, et al.
Translational Oncology
|
November 27, 2021
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma
Laura Kohtamäki, Mariliina Arjama, Siru Mäkelä, et al.
Page
of 19